MPC Therapeutics is Biotechnology in Switzerland that focus on inhibitor compound business. Founded in 2018. They cover business area such as developer, therapeutic, Geneva, Switzerland, class, MPC) inhibitor compound, metabolic and neurodegenerative disease.
2018
( 6 years old in 2024 )
Inhibitor Compound
-
Chemin des Aulx 14
Plan-les-Ouates
1228 Geneva
Switzerland
Private
developertherapeuticGenevaSwitzerlandclassMPC) inhibitor compoundmetabolic and neurodegenerative disease
* We use standard office opening hours in near MPC Therapeutics's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
MPC Therapeutics is Biotechnology business from Switzerland that founded in 2018 (6 years old in 2024), MPC Therapeutics business is focusing on Inhibitor Compound.
MPC Therapeutics headquarter office and corporate office address is located in Chemin des Aulx 14 Plan-les-Ouates 1228 Geneva Switzerland.
MPC Therapeutics was founded in Switzerland.
In 2024, MPC Therapeutics is currently focus on inhibitor compound sector.
Above is snippet of Google Trends for "inhibitor compound" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with MPC Therapeutics, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.